DeepThink PTB

Разработчик: Deepthink Health
Скачивания
Доход

Описание

DeepThink Health Precision Tumor Board ™
Advancing medicine with precision intelligence ™

DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Just as in the desktop Precision Tumor Board application, in our mobile app we’ve integrated and processed a cancer patient’s molecular/genomic tumor report enabling Molecular Tumor Board and Standard Tumor Board to quickly interpret the complex data for oncologists urgently needing to prescribe the right therapies for their cancer patients. Tumor Board members can:
• Quickly see FDA approved therapies with predictive responses for the patient’s specific tumor type and genetic characteristics
• Easily select among targeted therapies based on biomarkers or suggest therapies to enhance the molecular report interpretation
• See clinical trials already screened for the patient case in context
• Collaborate with other Molecular Tumor Board members to quickly and timely provide a succinct report to the treating oncologist
• Schedule and hold virtual tumor board meeting
• No private health information is stored or relayed in the application, DeepThink Health products are HIPAA compliant.

About DeepThink Health
DeepThink Health has developed an innovative precision intelligence platform which captures and structures large clinical and genomic datasets, and then applies our advanced analytics and machine learning to enable precision medicine. Our team has extensive experience and success in leading Healthcare IT companies serving providers, payers and pharmacies. Our Precision Analytics and Precision Intelligence solutions have been successfully implemented at large Healthcare IDNs where the combined genomic, clinical and outcome data were analyzed using DeepThink Artificial Intelligence tools to advance precision medicine and enable novel discoveries.
Скрыть Показать больше...

Скриншоты

DeepThink PTB Частые Вопросы

  • Приложение DeepThink PTB бесплатное?

    Да, DeepThink PTB полностью бесплатное и не содержит встроенных покупок или подписок.

  • Является ли DeepThink PTB фейковым или мошенническим?

    Недостаточно отзывов для надежной оценки. Приложению нужно больше отзывов пользователей.

    Спасибо за ваш голос

  • Сколько стоит DeepThink PTB?

    Приложение DeepThink PTB бесплатное.

  • Сколько зарабатывает DeepThink PTB?

    Чтобы получить оценку дохода приложения DeepThink PTB и другие данные AppStore, вы можете зарегистрироваться на платформе мобильной аналитики AppTail.

Оценки пользователей
Приложение еще не оценено в Южно-Африканская Республика.
История оценок

DeepThink PTB Отзывы Пользователей

Нет отзывов в Южно-Африканская Республика
Приложение пока не имеет отзывов в Южно-Африканская Республика.

Оценки

История позиций в топах
История рейтингов пока не доступна
Позиции в категории
Приложение еще не было в топах

DeepThink PTB Конкуренты

Name
ASTCT Practice Guidelines
BUMP by 4YouandMe
Skin Therapy Letter
Neuro-oncology: WTD
What's the data?
Immuno-Oncology
from @ Point of Care™
Skin Cancer Manager
Track Your Medical Journey
Washington Manual of Oncology
Cancer Tx in Outline Format
Philips IntelliSite Pathology
Medeligo
Luigi

DeepThink PTB Установки

30дн.

DeepThink PTB Доход

30дн.

DeepThink PTB Доходы и Загрузки

Получите ценные инсайты о производительности DeepThink PTB с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.